bisbenzimidazole analogs (ICR)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namebisbenzimidazole analogs (ICR)

Drug Alias NameDNA synthesis inhibitors (ICR)bisbenzimidazole analogs (Institute of Cancer Research)DNA synthesis inhibitors (Institute of Cancer Research)D-699126D-701062 +[6]

ClassificationSmall molecules

Mechanisms of ActionDNA synthesis inhibitors

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Cancer Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Cancer Research

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A